Michael Aaron Kelly's Net Worth
$1.44 Million
Who is Michael Aaron Kelly?
Michael Aaron Kelly has an estimated net worth of $1.44 Million. This is based on reported shares across multiple companies, which include NEOGENOMICS INC, DMC Global Inc., AMICUS THERAPEUTICS, INC., HOOKIPA Pharma Inc., Aprea Therapeutics, Inc., and Prime Medicine, Inc..
SEC CIK
Michael Aaron Kelly's CIK is 0001769668
Past Insider Trading and Trends
2020 was Michael Aaron Kelly's most active year for acquiring shares with 8 total transactions. Michael Aaron Kelly's most active month to acquire stocks was the month of May. 2024 was Michael Aaron Kelly's most active year for disposing of shares, totalling 1 transactions. Michael Aaron Kelly's most active month to dispose stocks was the month of July. 2022 saw Michael Aaron Kelly paying a total of $0.00 for 121,544 shares, this is the most they've acquired in one year. In 2024 Michael Aaron Kelly cashed out on 11,336 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NEOGENOMICS INC (NEO) Snapshot price: $16.04
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +55.52% | 11.34K |
—
|
—
| 31.75K |
Aug 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 10
| |||
Form 4
| +319.88% | 15.56K |
—
|
—
| 20.42K |
Jun 10
| |||
Form 4
| +172.90% | 3.08K |
—
|
—
| 4.86K |
Jun 2
| |||
Form 4
|
∞
| 1.78K |
—
|
—
| 1.78K |
Jul 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DMC Global Inc. (BOOM) Snapshot price: $11
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +59.37% | 9.52K |
—
|
—
| 25.55K |
May 15
| |||
Form 4
| +79.18% | 7.09K |
—
|
—
| 16.04K |
May 10
| |||
Form 4
| +126.96% | 5.01K |
—
|
—
| 8.95K |
May 11
| |||
Form 4
| +91.87% | 1.89K |
—
|
—
| 3.94K |
May 12
| |||
Form 4
|
∞
| 2.06K |
—
|
—
| 2.06K |
Jul 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AMICUS THERAPEUTICS, INC. (FOLD) Snapshot price: $11.65
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +29.47% | 11.85K |
—
|
—
| 52.05K |
Jun 6
| |||
Form 4
| +27.14% | 8.58K |
—
|
—
| 40.21K |
Jun 8
| |||
Form 4
| +66.86% | 12.67K |
—
|
—
| 31.62K |
Jun 9
| |||
Form 4
| +114.46% | 10.12K |
—
|
—
| 18.95K |
Jun 10
| |||
Form 4
|
∞
| 8.84K |
—
|
—
| 8.84K |
Dec 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HOOKIPA Pharma Inc. (HOOK) Snapshot price: $4.95
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
∞
| 5.75K |
—
|
—
| 5.75K |
Oct 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aprea Therapeutics, Inc. (APRE) Snapshot price: $3.48
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.61K |
—
|
—
| 4.61K |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||